Liraglutide + PYY

Autor: Valentin, Metzner, Gloria, Herzog, Tobias, Heckel, Thorsten, Bischler, Julia, Hasinger, Christoph, Otto, Martin, Fassnacht, Andreas, Geier, Florian, Seyfried, Ulrich, Dischinger
Rok vydání: 2021
Zdroj: Journal of clinical medicine. 11(3)
ISSN: 2077-0383
Popis: Treatment options for NAFLD are still limited. Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), has been shown to improve metabolic and histologic markers of NAFLD. Glucagon-like-peptide-1 (GLP-1) analogues lead to improvements in phase 2 clinical trials. We directly compared the effects of RYGB with a treatment using liraglutide and/or peptide tyrosine tyrosine 3-36 (PYYObese male Wistar rats (high-fat diet (HFD)-induced) were randomized into the following treatment groups: RYGB, sham-operation (sham), liraglutide (0.4 mg/kg/day), PYYRYGB and liraglutide+PYYThe combination therapy of liraglutide+PYY
Databáze: OpenAIRE